ECKERT & ZIEGLER SE (EUZ.DE) Stock Price, Quote, News and Overview
FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
EUZ.DE Quote, Performance and Key Statistics
FRA:EUZ (3/14/2025, 7:00:00 PM)
56.95
+1.55 (+2.8%)
The current stock price of EUZ.DE is 56.95 EUR. In the past month the price decreased by -4.69%. In the past year, price increased by 53.01%.
EUZ.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.09 | 201.53B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 66.32 | 159.66B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 66.34 | 159.23B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 38.74 | 132.08B | ||
| 2M6.DE | MEDTRONIC PLC | 17.41 | 109.44B | ||
| BOX.DE | BECTON DICKINSON AND CO | 16.13 | 59.15B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 23.22 | 58.93B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 22.84 | 57.98B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 25.87 | 36.66B | ||
| DC4.DE | DEXCOM INC | 42.55 | 25.28B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.59 | 22.98B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.57 | 22.95B |
Related stock screener links
About EUZ.DE
Company Profile
Eckert & Ziegler Strahlen- und Medizintechnik AG is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,143 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Company Info
ECKERT & ZIEGLER SE
Robert-Roessle-Str.10
Berlin BERLIN DE
Employees: 1085
Company Website: https://www.ezag.com/
Investor Relations: http://www.ezag.com/home/investors
Phone: 49309410840
ECKERT & ZIEGLER SE / EUZ.DE FAQ
What is the stock price of ECKERT & ZIEGLER SE today?
The current stock price of EUZ.DE is 56.95 EUR. The price increased by 2.8% in the last trading session.
What is the ticker symbol for ECKERT & ZIEGLER SE stock?
The exchange symbol of ECKERT & ZIEGLER SE is EUZ and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is EUZ.DE stock listed?
EUZ.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for ECKERT & ZIEGLER SE stock?
6 analysts have analysed EUZ.DE and the average price target is 64.41 EUR. This implies a price increase of 13.1% is expected in the next year compared to the current price of 56.95. Check the ECKERT & ZIEGLER SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ECKERT & ZIEGLER SE worth?
ECKERT & ZIEGLER SE (EUZ.DE) has a market capitalization of 1.21B EUR. This makes EUZ.DE a Small Cap stock.
How many employees does ECKERT & ZIEGLER SE have?
ECKERT & ZIEGLER SE (EUZ.DE) currently has 1085 employees.
What are the support and resistance levels for ECKERT & ZIEGLER SE (EUZ.DE) stock?
ECKERT & ZIEGLER SE (EUZ.DE) has a support level at 56.94 and a resistance level at 60.56. Check the full technical report for a detailed analysis of EUZ.DE support and resistance levels.
Is ECKERT & ZIEGLER SE (EUZ.DE) expected to grow?
The Revenue of ECKERT & ZIEGLER SE (EUZ.DE) is expected to grow by 21.88% in the next year. Check the estimates tab for more information on the EUZ.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ECKERT & ZIEGLER SE (EUZ.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EUZ.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EUZ.DE, evaluating the profitability, health, valuation and growth aspects
- ECKERT & ZIEGLER SE (EUZ.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ECKERT & ZIEGLER SE (EUZ.DE) Sales and EPS estimates to see what analysts future expectations are.
- ECKERT & ZIEGLER SE (EUZ.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ECKERT & ZIEGLER SE (EUZ.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- ECKERT & ZIEGLER SE (EUZ.DE) Stock Chart to make your own analysis
- ECKERT & ZIEGLER SE (EUZ.DE) Latest news and press-releases to stay up to date.
Does ECKERT & ZIEGLER SE (EUZ.DE) stock pay dividends?
ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 0.09%. The yearly dividend amount is currently 0.5. Check the full fundamental report for a detailed analysis of EUZ.DE dividend history, reliability and sustainability.
When does ECKERT & ZIEGLER SE (EUZ.DE) report earnings?
ECKERT & ZIEGLER SE (EUZ.DE) will report earnings on 2025-03-27, after the market close.
What is the Price/Earnings (PE) ratio of ECKERT & ZIEGLER SE (EUZ.DE)?
The PE ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 41.27. This is based on the reported non-GAAP earnings per share of 1.38 and the current share price of 56.95 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EUZ.DE.
EUZ.DE Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to EUZ.DE. When comparing the yearly performance of all stocks, EUZ.DE is one of the better performing stocks in the market, outperforming 96.9% of all stocks.
EUZ.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. Both the health and profitability get an excellent rating, making EUZ.DE a very profitable company, without any liquidiy or solvency issues.
EUZ.DE Financial Highlights
Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 1.38. The EPS increased by 9.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.58% | ||
| ROA | 6.11% | ||
| ROE | 11.83% | ||
| Debt/Equity | 0.17 |
EUZ.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to EUZ.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 55.27% and a revenue growth 21.88% for EUZ.DE